ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study to Determine an Effective Dose of Epoetin Alfa to Decrease the Number of Units of Blood Required to be Transfused During Hip Replacement Surgery.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00269971
Recruitment Status : Withdrawn
First Posted : December 26, 2005
Last Update Posted : September 20, 2016
Sponsor:
Information provided by:
Janssen-Ortho Inc., Canada

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Primary Completion Date : No date given
  Actual Study Completion Date : April 1999